(Q41178950)

27 September 2017

title

Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting response (English)

1 reference

27 September 2017

1 reference

Scully LJ

1

1 reference

27 September 2017

Brown D

2

1 reference

27 September 2017

Lloyd C

3

1 reference

27 September 2017

Shein R

4

1 reference

27 September 2017

Thomas HC

5

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

27 September 2017

number of pages

7

1 reference

inferred from page(s)

published in

Hepatology

1 reference

27 September 2017

volume

12

1 reference

27 September 2017

issue

5

1 reference

27 September 2017

page(s)

1111-1117

1 reference

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

Effects of Interferon and Adenine Arabinoside Treatment of Hepatitis B Virus Infection on Cellular Immune Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

Lymphoblastoid interferon therapy of chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Aetiology of acute sporadic hepatitis in adults in Kenya

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

On estimating the relation between blood group and disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

The estimation and significance of the logarithm of a ratio of frequencies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

HLA polymorphisms in Nigerians

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

HLA antigens in patients with various courses after hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

An immune response gene linked to MHC in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Genetic prediction of nonresponse to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Immunoregulatory T cell subsets in chronic hepatitis B virus infection: the influence of homosexuality.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Transcription of the human beta interferon gene is inhibited by hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Alpha-interferon. Its effect upon lymphocyte subpopulations and HLA-DR expression within the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Human Natural Killer Cell Activity is Augmented by Interferon via Recruitment of 'Pre-NK' Cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840120506

7 January 2021

Identifiers

DOI

10.1002/HEP.1840120506

1 reference

27 September 2017

1 reference